Vaccinating children as young as 6 months of age against COVID-19 may become the new front in the global pandemic fight, if the vaccines prove to be safe and effective.
One such trial by the American pharmaceutical company Moderna will begin enrolling children 6 months through 11 years old on Friday at the University of Wisconsin School of Medicine and Public Health. UW will be one of 75 to 100 sites in the U.S. and Canada for the trial, which has been named the KidCOVE study.